Britannia Life Sciences Inc. (FRA:L020)

Market Cap	7.03M +0.4%
Revenue (ttm)	295.03K +28.6%
Net Income	9.10M +98.2%
EPS	0.06 +98.2%
Shares Out	n/a
PE Ratio	0.77
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0285
Previous Close	0.0285
Day's Range	0.0285 - 0.0285
52-Week Range	0.0250 - 0.0710
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Britannia Life Sciences

Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. The company serves cosmetics, consumer packaged and household goods, and nutraceutical industries. Britannia Life Sciences Inc. is headquartered in Toronto, Canada.

• Industry: Testing Laboratories
• CEO: Peter Shippen
• Employees: 28
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: L020

Financial Performance

In fiscal year 2026, Britannia Life Sciences's revenue was 474,834, an increase of 28.58% compared to the previous year's 369,279. Earnings were 14.65 million, an increase of 98.18%.

Financial numbers in CAD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error